South Korea: Agricultural Biotechnology Annual

  |   Attaché Report (GAIN)   |   KS2022-0024

Korea is in the process of revising its Living Modified Organism (LMO) Act. Once completed, these revisions will define Korea’s regulatory policies for products that utilize innovative technologies, including genome editing. Finalized changes to the LMO Act are expected by the end of 2022 with implementation planned for the end of 2023. Additionally, Korea has announced mandatory biotech labeling will be required for all products containing biotech ingredients beginning in 2026.

Related Reports

The biotechnology regulatory system in Ukraine is still not fully developed, but the country is gradually adjusting its domestic policies to align with European Union regulations.
Attaché Report (GAIN)

Tunisia: Agricultural Biotechnology Annual

Tunisia is continuing to postpone non-urgent matters in front of major political and economic reforms. As a result, Tunisia’s biosafety framework, which was drafted in 2014, remains on hold with no timeframe for a review and parliamentary vote.
Attaché Report (GAIN)

Thailand: Rice Price - Weekly

Export prices of white and parboiled rice rose one percent from the previous week as exporters reportedly continued to secure the rice supplies to fulfill contract shipments.